A comparative study on three analytical methods for the determination of the neurotoxin BMAA in cyanobacteria

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Faassen, Elisabeth J ^a   Gillissen, Frits ^a   Lürling, Miquel ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID;

ANABAENA; APHANIZOMENON; ARTICLE; BACTERIUM DETECTION; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYANOBACTERIUM; CYCAS; ENVIRONMENTAL EXPOSURE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MICROCYSTIS; NONHUMAN; SCENEDESMUS; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

AMINO ACIDS, DIAMINO; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYANOBACTERIA; NEUROTOXINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

CYANOBACTERIA; CYCADOPSIDA;

EID: 84860499028     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036667     Document Type: Article

References (39)

1. Bradley WG, Mash DC, (2009) Beyond Guam: The cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotrophic Lateral Sclerosis 10: 7-20.
2. Vega A, Bell EA, (1967) α-amino-β-methylaminopropionic acid, a new amino acid from seeds of Cycas circinalis. Phytochemistry 6: 759-762.
3. Bell EA, (2009) The discovery of BMAA, and examples of biomagnification and protein incorporation involving other non-protein amino acids. Amyotrophic Lateral Sclerosis 10: 21-25.
4. Duncan MW, Steele JC, Kopin IJ, Markey SP, (1990) 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: An unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology 40: 767-772.
5. Cox PA, Sacks OW, (2002) Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 58: 956-959.
6. Cox PA, Banack SA, Murch SJ, (2003) Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proceedings of the National Academy of Sciences of the United States of America 100: 13380-13383.
7. Murch SJ, Cox PA, Banack SA, (2004) A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proceedings of the National Academy of Sciences of the United States of America 101: 12228-12231.
8. Banack SA, Murch SJ, Cox PA, (2006) Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. Journal of Ethnopharmacology 106: 97-104.
9. Murch SJ, Cox PA, Banack SA, Steele JC, Sacks OW, (2004) Occurrence of β-methylamino-L-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurologica Scandinavica 110: 267-269.
10. Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, et al. (2009) Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurologica Scandinavica 120: 216-225.
11. Cox PA, Banack SA, Murch SJ, Rasmussen U, Tien G, et al. (2005) Diverse taxa of cyanobacteria produce β-N-methylamino-L-alanine, a neurotoxic amino acid. Proceedings of the National Academy of Sciences of the United States of America 102: 5074-5078.
12. Johnson HE, King SR, Banack SA, Webster C, Callanaupa WJ, et al. (2008) Cyanobacteria (Nostoc commune) used as a dietary item in the Peruvian highlands produce the neurotoxic amino acid BMAA. Journal of Ethnopharmacology 118: 159-165.
13. Metcalf JS, Banack SA, Lindsay J, Morrison LF, Cox PA, et al. (2008) Co-occurrence of β-N-methylamino-L-alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990-2004. Environmental Microbiology 10: 702-708.
14. Jonasson S, Eriksson J, Berntzon L, Spáčil Z, Ilag LL, et al. (2010) Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proceedings of the National Academy of Sciences of the United States of America 107: 9252-9257.
15. Spáčil Z, Eriksson J, Jonasson S, Rasmussen U, Ilag LL, et al. (2010) Analytical protocol for identification of BMAA and DAB in biological samples. Analyst 135: 127-132.
16. Esterhuizen M, Downing TG, (2008) β-N-methylamino-L-alanine (BMAA) in novel South African cyanobacterial isolates. Ecotoxicology and Environmental Safety 71: 309-313.
17. Krüger T, Mönch B, Oppenhäuser S, Luckas B, (2010) LC-MS/MS determination of the isomeric neurotoxins BMAA (β-N-methylamino-L-alanine) and DAB (2,4-diaminobutyric acid) in cyanobacteria and seeds of Cycas revoluta and Lathyrus latifolius. Toxicon 55: 547-557.
18. Rosén J, Hellenäs KE, (2008) Determination of the neurotoxin BMAA (β-N-methylamino-L-alanine) in cycad seed and cyanobacteria by LC-MS/MS (liquid chromatography tandem mass spectrometry). Analyst 133: 1785-1789.
19. Moura S, Ultramari MdA, de Paula DML, Yonamine M, Pinto E, (2009) 1H NMR determination of β-N-methylamino-L-alanine (L-BMAA) in environmental and biological samples. Toxicon 53: 578-583.
20. Li A, Tian Z, Li J, Yu R, Banack SA, et al. (2010) Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China. Toxicon 55: 947-953.
21. Baptista MS, Cianca RCC, Lopes VR, Almeida CMR, Vasconcelos VM, (2011) Determination of the non protein amino acid β-N-methylamino-l-alanine in estuarine cyanobacteria by capillary electrophoresis. Toxicon 58: 410-414.
22. Esterhuizen-Londt M, Downing S, Downing TG, (2011) Improved sensitivity using liquid chromatography mass spectrometry (LC-MS) for detection of propyl chloroformate derivatised β-N-methylamino-L-alanine (BMAA) in cyanobacteria. Water SA 37: 133-138.
23. Faassen EJ, Gillissen F, Zweers HAJ, Lürling M, (2009) Determination of the neurotoxins BMAA (β-N-methylamino-L-alanine) and DAB (α-,γ-diaminobutyric acid) by LC-MSMS in Dutch urban waters with cyanobacterial blooms. Amyotrophic Lateral Sclerosis 10: 79-84.
24. Banack SA, Downing TG, Spáčil Z, Purdie EL, Metcalf JS, et al. (2010) Distinguishing the cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) from its structural isomer 2,4-diaminobutyric acid (2,4-DAB). Toxicon 56: 868-879.
25. Codd GA, Bell SG, Kaya K, Ward CJ, Beattie KA, et al. (1999) Cyanobacterial toxins, exposure routes and human health. European Journal of Phycology 34: 405-415.
26. Waters Corporation, (1993) Waters AccQ-Tag Chemistry Package Instruction Manual. Milford, MA Waters Corperation.
27. Eriksson J, Jonasson S, Papaefthimiou D, Rasmussen U, Bergman B, (2009) Improving derivatization efficiency of BMAA utilizing AccQ-Tag® in a complex cyanobacterial matrix. Amino Acids 36: 43-48.
28. Cohen SA, Michaud DP, (1993) Synthesis of a fluorescent derivatizing reagent, 6-aminoquinolyl-N- hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography. Analytical Biochemistry 211: 279-287.
29. Kaspar H, Dettmer K, Gronwald W, Oefner P, (2009) Advances in amino acid analysis. Analytical and Bioanalytical Chemistry 393: 445-452.
30. Bell EA, (2003) Nonprotein amino acids of plants: Significance in medicine, nutrition, and agriculture. Journal of Agricultural and Food Chemistry 51: 2854-2865.
31. Banack SA, Metcalf JS, Spáčil Z, Downing TG, Downing S, et al. (2011) Distinguishing the cyanobacterial neurotoxin β-N-methylamino-l-alanine (BMAA) from other diamino acids. Toxicon 57: 730-738.
32. Banack SA, Johnson HE, Cheng R, Cox PA, (2007) Production of the neurotoxin BMAA by a marine cyanobacterium. Marine Drugs 5: 180-196.
33. Sivonen K, Jones GJ, (1999) Cyanobacterial toxins. In: Chorus I, Bartram J, editors. Toxic Cyanobacteria in Water: A Guide to their Public Health Consequences, Monitoring and Management London E&FN Spon pp. 41-111.
34. Downing S, Banack SA, Metcalf JS, Cox PA, Downing TG, (2011) Nitrogen starvation of cyanobacteria results in the production of β-N-methylamino-L-alanine. Toxicon 58: 187-194.
35. Lürling M, Faassen EJ, Eenennaam JSV, (2011) Effects of the cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) on the survival, mobility and reproduction of Daphnia magna. Journal of Plankton Research 33: 333-342.
36. Lobner D, Piana PMT, Salous AK, Peoples RW, (2007) β-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms. Neurobiology of Disease 25: 360-366.
37. ICH, (1994) Text on Validation of Analytical Procedures Q2A. Washington, DC U.S. Food and Drug Administration.
38. ICH, (1996) Guidance for Industry, Q2B Validation of Analytical Procedures: Methodology. Washington, DC U.S. Food and Drug Administration.
39. Lurling M, Beekman W, (2006) Palmelloids formation in Chlamydomonas reinhardtii: Defence against rotifer predators? Annales de Limnologie 42: 65-72.